Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

41.

Advantages of a Truly Open-Access Data-Sharing Model.

N. Engl. J. Med.
Bertagnolli MM, Sartor O, Chabner BA, Rothenberg ML, Khozin S, Hugh-Jones C, Reese DM, Murphy MJ.
| Mar 23, 2017
42.

Case 9-2017.

N. Engl. J. Med.
Nagarur A, Axelrod L, Dighe AS.
| Mar 23, 2017
43.

Interleukin-12 and Interleukin-23 Blockade in Leukocyte Adhesion Deficiency Type 1.

N. Engl. J. Med.
Moutsopoulos NM, Zerbe CS, Wild T, Dutzan N, Brenchley L, DiPasquale G, Uzel G, Axelrod KC, Lisco A, Notarangelo LD, Hajishengallis G, Notarangelo LD, Holland SM.
| 03 23, 2017
44.

Ion and inhibitor binding of the double-ring ion selectivity filter of the mitochondrial calcium uniporter.

Proc. Natl. Acad. Sci. U.S.A.
Cao C, Wang S, Cui T, Su XC, Chou JJ.
| Mar 21, 2017
45.

Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.

Lancet.
Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, Güray Ü, Park DW, Bode C, Welsh RC, Gibson CM.
| Mar 17, 2017
46.

Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.

PLoS Med.
Desikan RS, Fan CC, Wang Y, Schork AJ, Cabral HJ, Cupples LA, Thompson WK, Besser L, Kukull WA, Holland D, Chen CH, Brewer JB, Karow DS, Kauppi K, Witoelar A, Karch CM, Bonham LW, Yokoyama JS, Rosen HJ, Miller BL, Dillon WP, Wilson DM, Hess CP, Pericak-Vance M, Haines JL, Farrer LA, Mayeux R, Hardy J, Goate AM, Hyman BT, Schellenberg GD, McEvoy LK, Andreassen OA, Dale AM.
| 03 21, 2017
47.

APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts.

PLoS Med.
Qian J, Wolters FJ, Beiser A, Haan M, Ikram MA, Karlawish J, Langbaum JB, Neuhaus JM, Reiman EM, Roberts JS, Seshadri S, Tariot PN, Woods BM, Betensky RA, Blacker D.
| 03 21, 2017
49.

Remediating "Lessons from the controversy over statins".

Lancet.
Abramson J, Rosenberg HG, Jewell N, Wright JM.
| Mar 18, 2017
50.

Safety and efficacy of statins.

Lancet.
Abramson J, Rosenberg HG, Jewell N, Wright JM.
| Mar 18, 2017
51.

A covalently bound inhibitor triggers EZH2 degradation through CHIP-mediated ubiquitination.

EMBO J.
Wang X, Cao W, Zhang J, Yan M, Xu Q, Wu X, Wan L, Zhang Z, Zhang C, Qin X, Xiao M, Ye D, Liu Y, Han Z, Wang S, Mao L, Wei W, Chen W.
| Mar 20, 2017
53.

Patient Mortality During Unannounced Accreditation Surveys at US Hospitals.

JAMA Intern Med.
Barnett ML, Olenski AR, Jena AB.
| Mar 20, 2017
54.

IRAP(+) endosomes restrict TLR9 activation and signaling.

Nat. Immunol.
Babdor J, Descamps D, Adiko AC, Tohmé M, Maschalidi S, Evnouchidou I, Vasconcellos LR, De Luca M, Mauvais FX, Garfa-Traore M, Brinkmann MM, Chignard M, Manoury B, Saveanu L.
| Mar 20, 2017
55.

Paying medicare advantage plans: To level or tilt the playing field.

J Health Econ.
Glazer J, McGuire TG.
| Dec 29, 2016
56.

Deletion of the MAD2L1 spindle assembly checkpoint gene is tolerated in mouse models of acute T-cell lymphoma and hepatocellular carcinoma.

Elife.
Foijer F, Albacker LA, Bakker B, Spierings DC, Yue Y, Xie SZ, Davis SH, Lutum-Jehle A, Takemoto D, Hare B, Furey B, Bronson RT, Lansdorp PM, Bradley A, Sorger PK.
| Mar 20, 2017
57.

Assessment of Stable Coronary Lesions.

N. Engl. J. Med.
Bhatt DL.
| Mar 18, 2017
58.

Phases of hyper and hypo connectivity in the Default Mode and Salience networks track with amyloid and Tau in clinically normal individuals.

J. Neurosci.
Schultz AP, Chhatwal JP, Hedden T, Mormino EC, Hanseeuw BJ, Sepulcre J, Huijbers W, LaPoint M, Buckley RF, Johnson KA, Sperling RA.
| Mar 17, 2017
59.

No back seat for a progression event-K-RAS as a therapeutic target in CRC.

Genes Dev.
Poulin EJ, Haigis KM.
| Feb 15, 2017
60.

PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation.

Mol. Cell.
Gupta A, Anjomani-Virmouni S, Koundouros N, Dimitriadi M, Choo-Wing R, Valle A, Zheng Y, Chiu YH, Agnihotri S, Zadeh G, Asara JM, Anastasiou D, Arends MJ, Cantley LC, Poulogiannis G.
| Mar 16, 2017